These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27242131)

  • 1. Bioengineered kidney tubules efficiently excrete uremic toxins.
    Jansen J; Fedecostante M; Wilmer MJ; Peters JG; Kreuser UM; van den Broek PH; Mensink RA; Boltje TJ; Stamatialis D; Wetzels JF; van den Heuvel LP; Hoenderop JG; Masereeuw R
    Sci Rep; 2016 May; 6():26715. PubMed ID: 27242131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.
    Mutsaers HA; Caetano-Pinto P; Seegers AE; Dankers AC; van den Broek PH; Wetzels JF; van den Brand JA; van den Heuvel LP; Hoenderop JG; Wilmer MJ; Masereeuw R
    Toxicol In Vitro; 2015 Oct; 29(7):1868-77. PubMed ID: 26216510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-Based Transport Assays Revisited in a Human Renal Proximal Tubule Cell Line.
    Caetano-Pinto P; Janssen MJ; Gijzen L; Verscheijden L; Wilmer MJ; Masereeuw R
    Mol Pharm; 2016 Mar; 13(3):933-44. PubMed ID: 26871298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters.
    Caetano-Pinto P; Jamalpoor A; Ham J; Goumenou A; Mommersteeg M; Pijnenburg D; Ruijtenbeek R; Sanchez-Romero N; van Zelst B; Heil SG; Jansen J; Wilmer MJ; van Herpen CML; Masereeuw R
    Mol Pharm; 2017 Jun; 14(6):2147-2157. PubMed ID: 28493713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A morphological and functional comparison of proximal tubule cell lines established from human urine and kidney tissue.
    Jansen J; Schophuizen CMS; Wilmer MJ; Lahham SHM; Mutsaers HAM; Wetzels JFM; Bank RA; van den Heuvel LP; Hoenderop JG; Masereeuw R
    Exp Cell Res; 2014 Apr; 323(1):87-99. PubMed ID: 24560744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
    Mutsaers HA; van den Heuvel LP; Ringens LH; Dankers AC; Russel FG; Wetzels JF; Hoenderop JG; Masereeuw R
    PLoS One; 2011 Apr; 6(4):e18438. PubMed ID: 21483698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Vitamin D in Maintaining Renal Epithelial Barrier Function in Uremic Conditions.
    Mihajlovic M; Fedecostante M; Oost MJ; Steenhuis SKP; Lentjes EGWM; Maitimu-Smeele I; Janssen MJ; Hilbrands LB; Masereeuw R
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one).
    Mizuno N; Takahashi T; Kusuhara H; Schuetz JD; Niwa T; Sugiyama Y
    Drug Metab Dispos; 2007 Nov; 35(11):2045-52. PubMed ID: 17682070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters.
    Kohler JJ; Hosseini SH; Green E; Abuin A; Ludaway T; Russ R; Santoianni R; Lewis W
    Lab Invest; 2011 Jun; 91(6):852-8. PubMed ID: 21403643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
    El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
    Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Translation of Microfluidic Transporter
    van der Made TK; Fedecostante M; Scotcher D; Rostami-Hodjegan A; Sastre Toraño J; Middel I; Koster AS; Gerritsen KG; Jankowski V; Jankowski J; Hoenderop JGJ; Masereeuw R; Galetin A
    Mol Pharm; 2019 Nov; 16(11):4551-4562. PubMed ID: 31525064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Amino Acid/Drug Transporters for Renal Transport of [
    Ono M; Baden A; Okudaira H; Kobayashi M; Kawai K; Oka S; Yoshimura H
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of uremic toxin transport by organic anion transporters in the kidney.
    Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
    Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of OAT1 Density and Functionality on Indoxyl Sulfate Transport in the Human Proximal Tubule: An Integrated Computational and In Vitro Study.
    King J; Mihaila SM; Ahmed S; Truckenmüller R; Giselbrecht S; Masereeuw R; Carlier A
    Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters.
    Wong CC; Barron D; Orfila C; Dionisi F; Krajcsi P; Williamson G
    Mol Nutr Food Res; 2011 Jul; 55(7):979-88. PubMed ID: 21538853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental expression of renal organic anion transporters in rat kidney and its effect on renal secretion of phenolsulfonphthalein.
    Nomura M; Motohashi H; Sekine H; Katsura T; Inui K
    Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1640-9. PubMed ID: 22419695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro evidence of enhanced breast cancer resistance protein-mediated intestinal urate secretion by uremic toxins in Caco-2 cells.
    Lu Y; Nakanishi T; Hosomi A; Komori H; Tamai I
    J Pharm Pharmacol; 2015 Feb; 67(2):170-7. PubMed ID: 25515305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.
    Wu W; Bush KT; Nigam SK
    Sci Rep; 2017 Jul; 7(1):4939. PubMed ID: 28694431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.